NCT07190079

Brief Summary

The goal of this observational study is to compare the consistency of saline contrast Electrical Impedance Tomography(EIT) method and Computed Tomography Pulmonary Angiography (CTPA) in diagnosing acute pulmonary embolism. The main question it aims to answer is: Can bedside saline contrast EIT method be used for the diagnosis of acute pulmonary embolism? The participants will undergo saline contrast EIT and CTPA examinations successively within 24 hours.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
343

participants targeted

Target at P75+ for all trials

Timeline
16mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress31%
Sep 2025Sep 2027

First Submitted

Initial submission to the registry

September 14, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 24, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

September 24, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2027

Last Updated

October 2, 2025

Status Verified

September 1, 2025

Enrollment Period

1.6 years

First QC Date

September 14, 2025

Last Update Submit

September 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The ability of proportion of dead space ventilation to diagnose PE

    The participant undergoes a saline contrast EIT examination, after which the distribution of pulmonary ventilation and perfusion will be obtained, respectively. A V-Q map will be subsequently generated. Using offline EIT data analysis tool, the proportion of lung regions with ventilation but without perfusion is calculated, representing the proportion of dead space ventilation (expressed as a percentage). Area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, Youden's index, accuracy, Kappa statistic, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR) and negative likelihood ratio (NLR) will be used to evaluate the ability of proportion of dead space ventilation to diagnose acute pulmonary embolism (PE).

    Within 24 hours before or after the CTPA examination

Secondary Outcomes (3)

  • The ability of proportion of V/Q matching to diagnose PE

    Within 24 hours before or after the CTPA examination

  • The ability of proportion of shunt to diagnose PE

    Within 24 hours before or after the CTPA examination

  • The ability of other indicators reflecting pulmonary ventilation and perfusion to diagnose PE

    Within 24 hours before or after the CTPA examination

Study Arms (1)

Patients clinically suspected with acute PE

This study will enroll adult patients (\>18 years) with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure, who either undergo computed tomography pulmonary angiography (CTPA) within 24 hours or are scheduled for CTPA within the next 24 hours. Eligible participants need to have an indwelling central venous catheter (internal jugular or subclavian vein) or a peripheral forearm venous line, with no restrictions on gender.

Diagnostic Test: Saline contrast Electrical Impedance Tomography methodDiagnostic Test: Computed Tomography Pulmonary Angiography (CTPA)

Interventions

This study will enroll patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure, who undergo electrical impedance tomography (EIT) with saline contrast within 24 hours before or after computed tomography pulmonary angiography (CTPA). The EIT procedure is performed as follows: 1. Breath-Hold Maneuver: (1)Spontaneous breathing patients: Supine position, instructed to hold expiration for ≥8 seconds. (2)Mechanically ventilated patients: Expiratory hold (\>8 sec) achieved via ventilator; deeper sedation will be applied when feasible to prolong breath-hold. 2. Venous Access: (1)Preferred: Central venous catheter (internal jugular or subclavian vein).(2)Alternative: Peripheral forearm vein (preferably the median cubital vein). 3. Contrast Administration:(1)Central venous route: 10 mL of 10% NaCl.(2)Peripheral venous route: 15 mL of 5% NaHCO₃.

Patients clinically suspected with acute PE

Patients who meet the inclusion criteria will undergo CTPA examination using conventional clinical diagnostic methods.

Patients clinically suspected with acute PE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure.

You may qualify if:

  • Patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure;
  • Availability of CTPA results within 24 hours or scheduled to undergo CTPA within the next 24 hours;
  • Age \>18 years; no gender restrictions;
  • Presence of central venous access (internal jugular or subclavian vein) or peripheral forearm venous access;
  • Willingness to participate with signed informed consent from either the patient or legal guardian.

You may not qualify if:

  • Pregnancy or lactation;
  • Relative contraindications to EIT examination (e.g., chest wall wounds at electrode belt placement site, presence of pacemakers);
  • Severe hypernatremia (serum sodium \>155 mmol/L);
  • Inability to maintain expiratory breath-hold for ≥8 seconds;
  • BMI \>50 or severe thoracic deformities;
  • Current extracorporeal membrane oxygenation (ECMO) therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences

Beijing, Beijing Municipality, 100730, China

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2025

First Posted

September 24, 2025

Study Start

September 24, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

September 15, 2027

Last Updated

October 2, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations